2037 Objectives: 1. Review the PET tracers and their targets in evaluating metastatic bone
disease. 2. Evaluate the relative utility of imaging bone turnover compared to imaging tumor …

Cancers prone to spread to bone include prostate, lung, kidney, breast and thyroid cancers.
While bone scanner has been widely used in the past decades, PET-based imaging …

Bone is among the most common locations of metastasis, and therefore represents an
important clinical target for diagnosis and follow-up in patients with cancer. Bone metastases …

P1575 Introduction: Bone metastasis detection methods such as X-ray, bone scan (BS), and
CT detect osseous changes only after a significant degree of macroscopic changes have …

Bone metastases are common, especially in more prevalent malignancies such as breast
and prostate cancer. They cause significant morbidity and draw on health-care resources …

Molecular imaging using bone targeted tracers has been used in clinical practice for almost
fifty years and still plays an essential role in the diagnosis and follow-up of bone metastases …

Purpose To assess 18 F-fluorodeoxyglucose (FDG) uptake in bone metastases in patients
with and without previous treatment, and compare positive positron emission tomography …

There is growing evidence that molecular imaging of bone metastases with positron-
emission tomography (PET) can improve diagnosis and treatment response assessment …

Background MR is an important imaging modality for evaluating musculoskeletal
malignancies owing to its high soft tissue contrast and its ability to acquire multiparametric …

BACKGROUND Positron emission tomography (PET) is a nuclear medicine technique that
only recently has been widely used in clinical oncology. PET, as a metabolic imaging …